WebSep 20, 2024 · This group of patients had locally advanced or metastatic disease and had not received prior systemic therapy. For the 147 people in the trial, objective response rate was 47.6%, which included some complete responses, and the disease control rate was 79.3% during a median follow up of 8.2 months. WebSep 24, 2024 · Another important endpoint for measuring the effectiveness of cancer drugs is progression-free survival, or PFS – how long a person lives without the disease …
OBJECTIVE RESPONSE RATE MESOTHELIOMA
WebApr 6, 2024 · Background Immune checkpoint inhibitors (ICIs) have dramatically changed the landscape of cancer treatment. However, only a few patients respond to ICI treatment. Thus, uncovering clinically accessible ICI biomarkers would help identify which patients will respond well to ICI treatment. A comprehensive objective response rate (ORR) data of … WebThe objective response rate was 31.6% in the FOLFIRINOX group versus 9.4% in the gemcitabine group (P<0.001). ... monotherapy in patients with locally advanced or metastatic pancreatic cancer ... highfield hospital widnes
NCI Dictionary of Cancer Terms
WebFeb 14, 2024 · Objective response rates and 95% CIs for subgroups of patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer. Data cutoff was February 1, 2024. Dashed line separates the objective response rate (ORR) for the overall HER2-low population from the that for the subgroups. WebWhen the primary endpoint of the study is objective response evaluation, ultrasound (US) should not be used to measure tumor lesions. It is, however, a possible alternative to … WebJun 1, 2015 · BackgroundGrowth of hormone-receptor–positive breast cancer is dependent on cyclin-dependent kinases 4 and 6 (CDK4 and CDK6), ... objective response, rate of clinical benefit, patient-reported ... highfield hospital in kenya